
Gilead Sciences
Biopharmaceutical company that discovers, develops, manufactures and commercializes therapies for critical diseases.
Market cap
$132.3b
Enterprise value
$143.6b
Share price
€68.88 GILD.MI
No columns specified
Biopharmaceutical company that discovers, develops, manufactures and commercializes therapies for critical diseases.